NEU 0.00% $19.97 neuren pharmaceuticals limited

Ann: 2023 Annual Report to shareholders, page-66

  1. 100 Posts.
    lightbulb Created with Sketch. 125
    "" achieving the best outcome for shareholders by pursuing value-adding opportunities to their fullest potential."

    This phrase is essentially meaningless, in the sense that it can be loosely translated as " we will continue doing what we should be doing in order to be doing our job"
    As Sherlock Holmes said, it is a capital mistake to theorise on the basis of insufficient data.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.